Sept 9 (Reuters) - KNIGHT THERAPEUTICS Inc GUD.TO :
* Says transaction with Medison Biotech closed; Knight acquired 28.3% equity
interest in Medison valued at $60 million
* Knight acquired 28.3% equity interest in Medison in exchange for
approximately a 10% equity interest in Knight
* Source text for Eikon ID:nMKWdyQWja
* Further company coverage GUD.TO